We are delighted to announce that ImVitro has raised $2.5M with LDV Capital, MMC Ventures & Tiny VC to get closer to the US market, make key technical and sales hires and add features to our main product to keep making our customers more efficient and effective.
We are very excited to be partnering with fantastic VC funds that can truly accelerate our growth in this next key chapter. LDV Capital is the only fund specialized in early stage ventures powered by visual technologies, has a great track record of helping technical teams succeed and at least 40% of their portfolio dedicated to healthcare. On the other hand, MMC has slightly more of a later stage focus with a great health portfolio to support us all the more in our commercialization effort. One is based in the US while the other in the UK, thus strengthening the international scope of the company.
Congratulations to the whole team for making this happen, and a big thank you to the many clinicians who have been using our tool in their lab making our dream of helping more and more patients become a reality!
Read the tech.eu article about the round here, and LDV Capital’s corresponding blog post here